Maria Grazia Valsecchi

Maria Grazia Valsecchi's AcademicInfluence.com Rankings

Physics

#7769

World Rank

#9823

Historical Rank

Astrophysics

#672

World Rank

#720

Historical Rank

physics Degrees

Download Badge

Physics

Maria Grazia Valsecchi's Degrees

PhD Physics University of Milan
Masters Physics University of Milan
Bachelors Physics University of Milan

Why Is Maria Grazia Valsecchi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Maria Grazia Valsecchi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genomewide Association Study of Severe Covid-19 with Respiratory Failure (2020) (1425)
Gene therapy for immunodeficiency due to adenosine deaminase deficiency. (2009) (926)
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome (2013) (812)
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. (2010) (697)
Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial (2002) (514)
Carotid Plaque Echolucency Increases the Risk of Stroke in Carotid Stenting: The Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) Study (2004) (461)
Mapping the human genetic architecture of COVID-19 (2021) (455)
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial (2007) (452)
Analysing Survival Data from Clinical Trials and Observational Studies; E. Marubini & M. G. Valsecchi Published by John Wiley & Sons 414 pages ISBN 0-971-93987-0. (1995) (433)
Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib. (2011) (388)
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. (2011) (356)
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia (2008) (334)
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study (2020) (326)
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials (1997) (308)
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study (2012) (273)
Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. (2009) (252)
Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. (2005) (233)
Clinical states of cirrhosis and competing risks. (2017) (230)
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. (2008) (217)
Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. (2008) (201)
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. (2016) (194)
Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. (2008) (188)
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study (2005) (185)
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. (2005) (180)
Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: a perspective from Central America. (2012) (172)
Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia. (2005) (165)
Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. (2009) (163)
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia (2019) (156)
Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. (2009) (150)
Improving outcomes for children with cancer in low‐income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)‐Part I (2007) (150)
Cancer registration in developing countries: luxury or necessity? (2008) (146)
Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. (2010) (145)
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study. (2010) (141)
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study. (2019) (137)
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. (2011) (131)
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL. (2014) (129)
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study (2019) (125)
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement (2007) (118)
IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. (2018) (117)
Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. (2012) (117)
Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T (2010) (115)
Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia. (2013) (112)
Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases. (2011) (111)
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts (2013) (111)
MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis (2014) (108)
Usefulness of waist circumference for the identification of childhood hypertension (2008) (107)
New policies to address the global burden of childhood cancers. (2013) (105)
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial (2007) (103)
Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association. (1995) (98)
Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia (2012) (98)
Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation. (2015) (97)
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II. (2002) (97)
Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants (2013) (94)
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan. (2005) (94)
Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy. (2016) (91)
Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization. (2008) (90)
Serum Uric Acid and Blood Pressure in Children at Cardiovascular Risk (2013) (89)
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis. (2016) (84)
Difference in Outcome of Adolescents with Acute Lymphoblastic Leukemia (ALL) Enrolled in Pediatric (AIEOP) and Adult (GIMEMA) Protocols. (2004) (80)
Asociación de Hemato‐Oncología Pediátrica de Centro América (AHOPCA): A model for sustainable development in pediatric oncology (2014) (79)
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia. (2010) (78)
Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years. (2002) (77)
Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)). (1990) (76)
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? (2014) (76)
Frailty index predicts poor outcome in COVID-19 patients (2020) (75)
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol. (2009) (75)
Preoperative Oral Carbohydrate Load Versus Placebo in Major Elective Abdominal Surgery (PROCY): A Randomized, Placebo-controlled, Multicenter, Phase III Trial (2017) (75)
Noninvasive Ventilatory Support of Patients with COVID-19 outside the Intensive Care Units (WARd-COVID) (2021) (74)
Nutritional status of children during treatment for acute lymphoblastic leukemia in Guatemala (2013) (73)
The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis (2020) (73)
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. (2008) (72)
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study. (2014) (71)
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia? (2013) (68)
Hypertension, prehypertension, and transient elevated blood pressure in children: association with weight excess and waist circumference. (2010) (68)
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry (2006) (66)
Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis (2019) (66)
Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. (1998) (65)
Marriage and parenthood among childhood cancer survivors: a report from the Italian AIEOP Off-Therapy Registry (2011) (65)
Psychological Aspects (2003) (64)
New concepts on the clinical course and stratification of compensated and decompensated cirrhosis (2018) (64)
Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia. (2007) (62)
Long term survivors of childhood cancer: cure and care. The Erice statement. (2007) (61)
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities. (2020) (61)
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial. (2018) (60)
Effects of exercise training on heart rate and QT interval in healthy young individuals: are there gender differences? (2007) (59)
FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia (2003) (58)
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000). (2017) (57)
Clinical and socio-demographic determinants of self-care behaviours in patients with heart failure and diabetes mellitus: A multicentre cross-sectional study. (2016) (57)
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak (2020) (56)
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. (2012) (56)
Improving recruitment to clinical trials for cancer in childhood. (2008) (54)
Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis (2017) (53)
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor a (2017) (52)
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children (2015) (50)
A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval. (2013) (50)
Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy (2018) (49)
Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study. (2019) (47)
Dexamethasone in Induction Can Eliminate One Third of All Relapses in Childhood Acute Lymphoblastic Leukemia (ALL): Results of An International Randomized Trial in 3655 Patients (Trial AIEOP-BFM ALL 2000) (2008) (47)
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery. (2019) (46)
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer. (1997) (45)
Prediction of progression‐free survival in patients presenting with hepatocellular carcinoma within the Milan criteria (2010) (45)
Risk factors for highly pathogenic H7N1 avian influenza virus infection in poultry during the 1999-2000 epidemic in Italy. (2009) (44)
Cardiovascular risk assessment in children: role of physical activity, family history and parental smoking on BMI and blood pressure (2013) (44)
Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I. (2015) (43)
Clinical epidemiology of childhood cancer in Central America and Caribbean countries. (2004) (42)
Delirium in Patients with SARS‐CoV‐2 Infection: A Multicenter Study (2020) (42)
Adiponectin and hypertension in normal-weight and obese children. (2013) (42)
Acute lymphoblastic leukemia and Down syndrome (2008) (42)
Correspondence between neurophysiological and clinical measurements of chemotherapy‐induced peripheral neuropathy: secondary analysis of data from the CI‐PeriNomS study (2014) (41)
Multi-Center Randomized Controlled Trial on the Effect of Triclosan-Coated Sutures on Surgical Site Infection after Colorectal Surgery. (2015) (41)
Survival after relapse in children with solid tumors: A follow‐up study from the Italian off‐therapy registry (2006) (41)
Evaluation of long-term survival: use of diagnostics and robust estimators with Cox's proportional hazards model. (1996) (40)
Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study. (2010) (40)
Allogeneic bone marrow transplantation versus chemotherapy in high‐risk childhood acute lymphoblastic leukaemia in first remission (1997) (39)
Prognostic factors and risk groups: some results given by using an algorithm suitable for censored survival data. (1983) (39)
High prevalence of hypertension in normal and underweight Indian children (2011) (39)
Short-term respiratory outcomes in late preterm infants (2014) (38)
Increased Serum Uric Acid Levels Blunt the Antihypertensive Efficacy of Lifestyle Modifications in Children at Cardiovascular Risk (2016) (38)
Challenges for children and adolescents with cancer in Europe: The SIOP-Europe agenda (2014) (38)
Outcome of very late relapse in children with acute lymphoblastic leukemia. (2004) (38)
Screening for Coagulopathy and Identification of Children With Acute Lymphoblastic Leukemia at a Higher Risk of Symptomatic Venous Thrombosis: An AIEOP Experience (2013) (37)
Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group (2015) (37)
ADC maps in the prediction of pelvic lymph nodal metastatic regions in endometrial cancer (2012) (37)
Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes. (2007) (37)
Maternal polymorphisms for methyltetrahydrofolate reductase and methionine synthetase reductase and risk of children with Down syndrome. (2009) (37)
Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response (2002) (36)
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: A report from the children's oncology group (2015) (36)
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome. (2021) (36)
The controversy of varicella vaccination in children with acute lymphoblastic leukemia (2012) (36)
Ethmoid Adenocarcinoma—From Craniofacial to Endoscopic Resections (2011) (35)
Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course. (2005) (35)
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry. (2019) (33)
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age (2012) (33)
Cardiovascular Risk Factors Associated With the Metabolically Healthy Obese (MHO) Phenotype Compared to the Metabolically Unhealthy Obese (MUO) Phenotype in Children (2020) (32)
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (2017) (31)
Perfusion Computed Tomographic Assessment of Early Hepatocellular Carcinoma in Cirrhotic Liver Disease: Initial Observations (2008) (31)
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol (2018) (31)
A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for intergroup collaboration. (1996) (30)
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. (2006) (29)
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results (2017) (29)
Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI (2017) (29)
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols (2019) (28)
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP‐BFM ALL protocols (2018) (28)
Impact of Continuous vs Bolus Feeding on Splanchnic Perfusion in Very Low Birth Weight Infants: A Randomized Trial. (2016) (28)
A weighted Kaplan–Meier estimator for matched data with application to the comparison of chemotherapy and bone‐marrow transplant in leukaemia (2002) (27)
Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia. (2014) (26)
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (2020) (25)
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia (2011) (25)
Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study (2017) (25)
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 (2021) (25)
Pharmacokinetics of high‐dose methotrexate in infants treated for acute lymphoblastic leukemia (2009) (25)
Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol (2020) (25)
Enoxaparin for thromboprophylaxis in hospitalized COVID‐19 patients: The X‐COVID‐19 Randomized Trial (2021) (24)
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study (2022) (24)
Optimal cut-point definition in biomarkers: the case of censored failure time outcome (2015) (24)
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System. (2020) (24)
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study (2019) (24)
A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders (2022) (24)
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis (2016) (24)
Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol (2010) (24)
Glutamine-Enriched Nutrition Does Not Reduce Mucosal Morbidity or Complications After Stem-Cell Transplantation for Childhood Malignancies: A Prospective Randomized Study (2011) (24)
Nomograms to identify elevated blood pressure values and left ventricular hypertrophy in a paediatric population: American Academy of Pediatrics Clinical Practice vs. Fourth Report/European Society of Hypertension Guidelines (2019) (23)
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial (2012) (23)
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis. (2020) (22)
Modelling the relative risk of esophageal cancer in a case-control study. (1992) (22)
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study (2021) (22)
Age-sex population adjusted analysis of disease severity in epidemics as a tool to devise public health policies for COVID-19 (2021) (22)
CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) (2017) (22)
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia (2014) (22)
Long-term survivors of childhood cancer: cure and care—the Erice Statement (2006) revised after 10 years (2016) (2018) (21)
A randomized and controlled study of noninvasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients (2015) (21)
Chromosomal Aberrations in Bladder Cancer: Fresh versus Formalin Fixed Paraffin Embedded Tissue and Targeted FISH versus Wide Microarray-Based CGH Analysis (2011) (21)
Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment (2016) (21)
Enhanced recovery strategies in colorectal surgery: is the compliance with the whole program required to achieve the target? (2014) (20)
Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients (2016) (20)
Low PKCa expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome (2014) (20)
Iron Accumulation in Chronic Hepatitis C (2005) (20)
Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study (2021) (20)
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia. (2013) (20)
Possible Role of Pandemic AH1N1 Swine Flu Virus in a Childhood Leukemia Cluster (2017) (20)
Childhood acute lymphoblastic leukemia in Nicaragua: Long‐term results in the context of an international cooperative program (2014) (20)
Evaluation of splanchnic oximetry, Doppler flow velocimetry in the superior mesenteric artery and feeding tolerance in very low birth weight IUGR and non-IUGR infants receiving bolus versus continuous enteral nutrition (2012) (20)
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time (2008) (19)
A single high dose of idarubicin combined with high‐dose ARA‐C for treatment of first relapse in childhood ‘high‐risk’ acute lymphoblastic leukaemia: a study of the AIEOP group (2002) (19)
Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis (2020) (19)
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE‐related hemochromatosis (2016) (19)
Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia (2015) (19)
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia (2017) (19)
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve (2018) (19)
Single-Incision Versus Standard Multiple-Incision Laparoscopic Cholecystectomy (2014) (19)
From LI-RADS Classification to HCC Pathology: A Retrospective Single-Institution Analysis of Clinico-Pathological Features Affecting Oncological Outcomes after Curative Surgery (2022) (18)
Patients' and physicians' interpretation of chemotherapy‐induced peripheral neurotoxicity (2019) (18)
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study. (2005) (18)
Oxidative stress biomarkers and chromogranin A in uremic patients: effects of dialytic treatment. (2010) (17)
Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validation (2022) (17)
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells (2018) (17)
Remdesivir Use in Patients Requiring Mechanical Ventilation due to COVID-19 (2020) (17)
Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities (2016) (17)
Joint model robustness compared with the time-varying covariate Cox model to evaluate the association between a longitudinal marker and a time-to-event endpoint (2019) (17)
Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation (2003) (17)
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups (2014) (17)
Glutathione S-transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. (2012) (17)
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis (2020) (16)
Early transoesophageal echocardiography in cryptogenic and lacunar stroke and transient ischaemic attack (1998) (16)
Comparison of three therapeutic regimens for genotype‐3 hepatitis C virus infection in a large real‐life multicentre cohort (2020) (15)
Vincristine (VCR) - Dexamethasone (DEXA) Pulses for Intermediate Risk (IR) Childhood Acute Lymphoblastic Leukemia (ALL) Treated with BFM Based Protocols: Results of the I-BFM-SG ALL IR 95 Study. (2005) (15)
Measures of single arm outcome in meta‐analyses of rare events in the presence of competing risks (2015) (15)
Targeting FLT 3 in primary MLL-gene – rearranged infant acute lymphoblastic leukemia (2005) (15)
Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience. (1997) (15)
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to “Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute ly (2013) (15)
Axillary lymphadenectomy for breast cancer. A randomized controlled trial comparing a bipolar vessel sealing system to the conventional technique. (2012) (14)
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial (2019) (14)
Strategy to identify priority groups for COVID-19 vaccination: A population based cohort study (2021) (14)
Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study (2022) (14)
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia (2021) (14)
Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment (2010) (14)
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy (2020) (14)
The nephrologist’s anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation (2014) (14)
Survival probabilities with time‐dependent treatment indicator: quantities and non‐parametric estimators (2016) (14)
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor (2018) (14)
Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach (2017) (14)
Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols (2020) (13)
New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations (2021) (13)
Detailed stratified GWAS analysis for severe COVID-19 in four European populations (2022) (13)
Pulse wave velocity progression over a medium‐term follow‐up in hypertensives: Focus on uric acid (2019) (13)
Multivariate permutation test to compare survival curves for matched data (2012) (12)
A unified model for estimating and testing familial aggregation (2013) (12)
Acute Myocarditis Associated With Desmosomal Gene Variants. (2022) (12)
Philadelphia-Like Signature In Childhood Acute Lymphoblastic Leukemia: The AIEOP Experience (2013) (12)
Atrial Fibrillation and Clinical Outcomes in a Cohort of Hospitalized Patients with Sars-Cov-2 Infection and Chronic Kidney Disease (2021) (12)
Uric acid in chronic coronary syndromes: Relationship with coronary artery disease severity and left ventricular diastolic parameter. (2021) (12)
Effects of Lifestyle Modifications on Elevated Blood Pressure and Excess Weight in a Population of Italian Children and Adolescents (2018) (11)
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study. (2019) (11)
Feeding tolerance of preterm infants appropriate for gestational age (AGA) as compared to those small for gestational age (SGA) (2013) (11)
Reduced Intensity Delayed Intensification in Standard-Risk Patients Defined By Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia: Results of an International Randomized Trial in 1164 Patients (Trial AIEOP-BFM ALL 2000) (2016) (11)
Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemia (2003) (11)
Peri-intubation Cardiovascular Collapse in Critically Ill Patients: Insights from the INTUBE Study. (2022) (10)
The Care and Outcomes of Older Persons with Lung Cancer in England and the United States, 2008–2012 (2018) (10)
Indicators based on registers and administrative data for breast cancer: routine evaluation of oncologic care pathway can be implemented. (2016) (10)
The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7–9, 2011 (2013) (10)
Effectiveness of treatments for acute and sub-acute mechanical non-specific low back pain: protocol for a systematic review and network meta-analysis (2019) (10)
Ordinal Outcomes Are Superior to Binary Outcomes for Designing and Evaluating Clinical Trials in Compensated Cirrhosis (2019) (10)
Impact of Minimal Residual Disease (MRD) on Prognosis in Children with Acute Lymphoblastic Leukemia (ALL) According to WBC Count, Age and TEL/AML1 Status at Diagnosis. Results of the AIEOP-BFM ALL 2000 Study. (2007) (9)
The effect of frailty on in-hospital and medium-term mortality of patients with COronaVIrus Disease-19: the FRACOVID study. (2021) (9)
Risk of repeated febrile episodes during chemotherapy-induced granulocytopenia in children with cancer: a prospective single center study (2012) (9)
Utility of precipitating antibody testing in the diagnostic evaluation of chronic hypersensitivity pneumonia (2017) (9)
Bone marrow transplantation for childhood hematological disorders: a global pediatric approach in a twelve year single center experience. (2000) (9)
RECURRENT GENETIC FUSIONS REDEFINE MLL-GERMLINE ACUTE LYMPHOBLASTIC LEUKEMIA IN INFANTS. (2020) (9)
Maternal perception of excess weight in children: A survey conducted by paediatricians in the province of Milan (2005) (8)
The relationship between frailty and delirium: insights from the 2017 Delirium Day study. (2021) (8)
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I (2017) (8)
Cerebrospinal fluid analysis by 8-color flow cytometry in children with acute lymphoblastic leukemia (2019) (8)
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia (2018) (8)
Heart Rate in Patients with SARS-CoV-2 Infection: Prevalence of High Values at Discharge and Relationship with Disease Severity (2021) (7)
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison. (2020) (7)
Performance of binary markers for censored failure time outcome: nonparametric approach based on proportions (2012) (7)
Monocyte–macrophage polarization and recruitment pathways in the tumour microenvironment of B‐cell acute lymphoblastic leukaemia (2021) (7)
How do self-care maintenance, self-care monitoring, and self-care management affect glycated haemoglobin in adults with type 2 diabetes? A multicentre observational study (2020) (7)
Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia Pediatrica. (1998) (7)
The association between low skeletal muscle mass and delirium: results from the nationwide multi-centre Italian Delirium Day 2017 (2021) (7)
A Phase 2 Study to Test the Feasibility, Safety and Efficacy of the Addition of Blinatumomab to the Interfant06 Backbone in Infants with Newly Diagnosed KMT2A-Rearranged Acute Lymphoblastic Leukemia. a Collaborative Study of the Interfant Network (2021) (7)
Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: the need to present minimal important differences units in meta-analyses (2018) (7)
Efficacy and Safety of Imatinib on Top of BFM-Like Chemotherapy in Pediatric Patients with Ph+/BCR-ABL+ Acute Lymphoblastic Leukemia (Ph+ALL). the EsPhALL Study (2011) (7)
Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients. (2009) (6)
Web‐based international studies in limited populations of pediatric leukemia (2008) (6)
Uric acid is associated with acute heart failure and shock at presentation in ACS patients. (2022) (6)
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia. (2021) (6)
Outcome of Infants Younger Than 1 Year with Acute Lymphoblastic Leukemia Treated with the Interfant-06 Protocol; Results from an International Randomised Study (2018) (6)
Chromosome-Positive ( Ph 1 ) Childhood Acute Lymphoblastic Leukemia : Good Initial Steroid Response Allows Early Prediction of a Favorable Treatment Outcome (1998) (6)
Report On Excessive Induction Toxicity in Infants with ALL Enrolled On COG Protocol AALL0631: A Children's Oncology Group Study. (2009) (6)
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation (2016) (6)
MTHFR 677C→T mutation and neural-tube defects (1997) (6)
Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia. (2016) (6)
Safety and Clinical Benefit of Lentiviral Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome (2015) (6)
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patients (2020) (6)
Crude incidence in two-phase designs in the presence of competing risks (2016) (6)
HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemia (2020) (6)
Autologous purified peripheral blood stem cell transplantation compare to chemotherapy in childhood acute lymphoblastic leukemia after low‐risk relapse (2011) (6)
Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Wiskott-Aldrich Syndrome (WAS): Up to 8 Years of Follow up in 17 Subjects Treated Since 2010 (2019) (5)
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study (2021) (5)
Non-invasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients: effects on home blood pressure in the BEAUTY study (2018) (5)
Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study (2021) (5)
Graphical representations and summary indicators to assess the performance of risk predictors (2016) (5)
Best quality indicator of vitamin K antagonist therapy to predict mortality and bleeding in haemodialysis patients with atrial fibrillation. (2020) (5)
Kinesio taping for rotator cuff disease. (2021) (5)
Incidence of Hypersensitivity Reactions (HSR) Reactions (HSR) to Peg-Asparaginase (PEG-ASP) in 6136 Patients Treated in the AIEOP-BFM ALL 2009 Study Protocol (2019) (5)
[The contribution of the Italian Association of paediatric haematology and oncology (AIEOP)]. (2016) (5)
Impact of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study (2021) (4)
Mechanical Ventilation in COVID-19 Patients: Insights into the Role of Age and Frailty from a Multicentre Observational Study (2022) (4)
Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP) (2018) (4)
Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks (2019) (4)
Survival estimation in two-phase cohort studies with application to biomarkers evaluation (2016) (4)
Digital-Droplet PCR, an Accurate Method for IG/TR PCR-MRD Stratification in Childhood Acute Lymphoblastic Leukemia (2018) (4)
Using multiple timescale models for the evaluation of a time‐dependent treatment (2015) (4)
Children with TEL/AML1-Positive Acute Lymphoblastic Leukemia (ALL) and Favorable Presenting Features May Benefit from the Use of Vincristine-Dexamethasone (VCR-DXM) Pulses on Top of Antimetabolite-Based Continuation Therapy. (2005) (4)
Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point (2020) (4)
Time Point-Dependent Concordance of Flow Cytometry and RQ-PCR in the MRD Detection in Childhood ALL: The Experience of the AIEOP-BFM- ALL MRD Study Group (2008) (4)
Evaluation of alternative prognostic stratifications by prediction accuracy measures on individual survival with application to childhood leukaemia. (2009) (4)
Early evaluation of bone marrow minimal residual disease by flowcytometry on day 15 is feasible on a multicenter basis and bears strong prognostic value in childhood acute lymphoblastic leukemia. The AIEOP-BFM experience (2007) (4)
Trends in all-cause mortality of hospitalized patients due to SARS-CoV-2 infection from a monocentric cohort in Milan (Lombardy, Italy) (2022) (4)
Prevalence of hypertension mediated organ damage in subjects with high-normal blood pressure without known hypertension as well as cardiovascular and kidney disease (2021) (4)
Health Related Quality of Life in the Major Liver Conditions (2013) (4)
Long-term survivors of childhood cancer: Cure and care. The Erice Statement (2009) (4)
Classification and Treatment of Acute Lymphoblastic Leukemia (2011) (3)
Machine learning in primary biliary cholangitis: A novel approach for risk stratification (2021) (3)
Outcome of Early T-Cell Precursor Acute Lymphoblastic Leukemia in AIEOP Patients Treated with the AIEOP-BFM ALL 2000 Study (2014) (3)
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging. (2020) (3)
Imatinib Long Term Effects (ILTE) Study: An Independent, International Study in CML Patients. (2008) (3)
NUTM1-Rearranged Infant and Pediatric B Cell Precursor Acute Lymphoblastic Leukemia: A Good Prognostic Subtype Identified in a Collaborative International Study (2020) (3)
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases. (2014) (3)
Prognostic factors analysis in clinical oncology: handle with care. (1991) (3)
Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19 (2022) (3)
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life (2013) (3)
Body temperature at nursery admission in a cohort of healthy newborn infants: results from an observational cross-sectional study (2020) (3)
Clonal Evolution and Lack of BCR-ABL1 Mutations in Pediatric Ph+ ALL Patients Resistant/Refractory to Imatinib Treatment (2015) (3)
Effects of antenatal indomethacin on ductus arteriosus early closure and on adverse outcomes in preterm neonates (2018) (3)
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia (2022) (3)
Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now? (2007) (3)
Next‐generation sequencing of PTEN mutations for monitoring minimal residual disease in T‐cell acute lymphoblastic leukemia (2020) (3)
Treatment of childhood acute lymphoblastic leukemia in first remission with allogeneic bone marrow transplantation or with intensive chemotherapy: a cooperative Italian study. The AIEOP (Associazione Italiana Ematologia ed Oncologia Pediatrica) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo), (1996) (3)
Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL (2011) (3)
[A set of indicators to monitor the adherence to the guidelines for the diagnosis and treatment of breast cancer]. (2014) (3)
Prognostic Impact of Minimal Residual Disease (MRD) in Children Is Different in B or T Lineage Acute Lymphoblastic Leukemia: Results of Trial AIEOP-BFM ALL 2000. (2007) (3)
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023) (3)
Predictors of failure of transoesophageal cardioversion of common atrial flutter. (2001) (2)
Complexity of nursing care at 24 h from admission predicts in-hospital mortality in medical units: a cohort study (2020) (2)
Treatment Intensification of Traditional BFM Therapy with 3 Chemotherapy Blocks and Double Delayed Intensification (Protocol II) Improves Outcome in Infants with High Risk (HR) Acute Lymphoblastic Leukemia (ALL): Results of Two Consecutive AIEOP Studies. (2005) (2)
Dexamethasone Stimulation Test in the Diagnostic Work-Up of Growth Hormone Deficiency in Childhood: Clinical Value and Comparison With Insulin-Induced Hypoglycemia (2020) (2)
Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (2018) (2)
Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients (2022) (2)
High Dose Methotrexate (HD MTX at 2 gr/sqm x 4) Associated to Extended Intrathecal (IT) Chemotherapy Is Effective for Prevention of Central Nervous System (CNS) Relapse in Childhood ALL Treated with BFM Systemic Therapy. (2005) (2)
Double outlet right ventricle with atrioventricular discordance. Report on cases having situs solitus, dextrocardia, pulmonary stenosis and levomalposition of the aorta. (1984) (2)
Autologous bone marrow transplantation for extramedullary relapse in childhood leukemia. The AIEOP Group and the FONOP. Italian Association of Pediatric Hemato/Oncology. (1996) (2)
Assessing the effect of a partly unobserved, exogenous, binary time-dependent covariate on survival probabilities using generalised pseudo-values (2018) (2)
Patterns of recurrences in sinonasal cancers undergoing an endoscopic surgery-based treatment: Results of the MUSES* on 940 patients: *MUlti-institutional collaborative Study on Endoscopically treated Sinonasal cancers. (2022) (2)
Robust non‐parametric one‐sample tests for the analysis of recurrent events (2010) (2)
Delirium and Clusters of Older Patients Affected by Multimorbidity in Acute Hospitals. (2021) (2)
NUP214–ABL1 fusion in childhood T‐ALL (2022) (2)
TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype. (2014) (2)
Importance of minimal residual disease testing during the second year of disease: still no answer? (2003) (2)
Effects of the Switch to Generic Imatinib in a Cohort of 109 Italian CML Patients - the Gims Study (2018) (2)
Tetralogy of Fallot with absent pulmonary valve: definitive diagnosis by two-dimensional echocardiography. (1983) (2)
A Treatment Protocol with Imatinib and Intensive Chemotherapy for Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia: A Single-Arm, Intergroup Study (Esphall 2010) (2018) (2)
Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL. (2017) (2)
Liver-Directed Adeno-Associated Virus–Mediated Gene Therapy for Mucopolysaccharidosis Type VI (2022) (2)
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery. (2022) (1)
Late Development of Cytogenetic Abnormalities in Ph Negative Cells of Chronic Myeloid Leukemia Patients Treated with Imatinib. (2009) (1)
[The usefulness of transesophageal echocardiography in the diagnosis of arrhythmogenic cardiomyopathy of the right ventricle]. (1993) (1)
Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment. (2021) (1)
Donor-Derived CAR T Cells Engineered with Sleeping Beauty Achieve Anti-Leukemic Activity without Severe Toxicity (2020) (1)
P1281 GENERATION AND PERFORMANCE OF VALUE-BASED OUTCOME INDICATORS IN LIVER DISEASE: THE MULTICENTER V.B.M.H. STUDY (2014) (1)
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) (2022) (1)
Final Results of Phase I/II Study of Donor-Derived CAR T Cells Engineered with Sleeping Beauty in Pediatric and Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed Post-HSCT (2022) (1)
468. GLP-Compliant Non-Clinical Safety and Biodistribution of a Recombinant AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI (2016) (1)
FLT3-ITD As a Target for Minimal Residual Disease Monitoring in Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia (2014) (1)
Detection of CALM-AF10 Fusion Transcript Does Not Predict A Poor Prognosis in Children with T-Lineage Acute Lymphoblastic Leukemia Treated with AIEOP ALL 2000 Protocol and Subsequent Modified 2000 Study (R-2006). (2009) (1)
[Methodologic problems in the analysis of competing risks]. (2002) (1)
Gene expression proﬁles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children’s Oncology Group study (2012) (1)
Relapse in Childhood “Very High Risk” Acute Lymphoblastic Leukemia Treated with BFM Chemotherapy Has a Dismal Outcome Even When Treated with Transplantation. (2008) (1)
MANAGING CARDIOVASCULAR RISK IN HYPERTENSION: METHODOLOGICAL ISSUES IN BLOOD PRESSURE DATA ANALYSIS (2017) (1)
A causal inference approach to compare leukaemia treatment outcome in the absence of randomization and with dependent censoring. (2021) (1)
Strategies for Trial Design and Analyses (2011) (1)
The impact of liver disease on the health-related quality of life (2014) (1)
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease (2022) (1)
Pre-Clinical Efficacy of the Novel Kinase Inhibitor Nintedanib on PAX5 Fusion Genes in Pediatric Ph-like B-Cell Precursor Acute Lymphoblastic Leukemia (2019) (1)
Gene therapy with hematopoietic stem and progenitor cell for monogenic disorders: a systematic review and meta-analysis (2021) (1)
Preoperative Oral Carbohydrate Load Versus Placebo in Major Elective Abdominal Surgery ( PROCY ) lled , Multicenter , Phase III Trial A Randomized , Placebo-contro (2017) (1)
Impact of Minimal Residual Disease (MRD) on Prognosis in Children with Philadelphia Positive Acute Lymphoblastic Leukemia (ALL) Treated in the AIEOP-BFM ALL 2000 Study. (2008) (1)
Analysis of interval‐censored longitudinal data with application to onco‐haematology (2005) (1)
A Childhood Leukaemia Cluster in Milan: Possible Role of Pandemic AH1N1 Swine Flu Virus. (2012) (1)
Poor Prognosis for IKZF1 Intra-Gene Deletions in Pediatric Ph– B-Cell Precursor Acute Lymphoblastic Leukemia (2011) (1)
Clinical Impact of Spontaneous Portosystemic Shunts in Liver Transplantation: A Comprehensive Assessment Through Total Shunt Area Measurement (2022) (1)
TEL/AML1 Rearrangement Is Rare in Children with Acute Lymphoblastic Leukemia (ALL) and Down Syndrome (DS). Presenting Features and Treatment Outcome in the Experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). (2007) (1)
Efficacy and Safety of Extracranial Vein Angioplasty inMultiple Sclerosis A Randomized Clinical Trial (2018) (1)
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators (2014) (1)
Imatinib Long Term Effects (ILTE) Study: An International Study to Evaluate Long-Term Effects in CML Patients. (2009) (1)
Comprar Play Therapy Theory and Practice: Comparing Theories and Techniques | Ettore Marubini | 9780470122365 | Wiley (2009) (1)
Infant T‐cell acute lymphoblastic leukaemia with t(6;7) (TCRB‐MYB) translocation (2021) (1)
Cancer of the head and neck: a set of indicators based on register and administrative data. (2018) (1)
Biological Features and Prognostic Impact of CRLF2 Overexpression In Childhood ALL (2010) (1)
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases (2012) (1)
Modeling the hazard of transition into the absorbing state in the illness‐death model (2019) (1)
The Role for Tocilizumab in COVID-19 Patients: Reflections on Monza Cohort Data (2021) (1)
Activin A, a Potential Key Factor of the Malignant Bone Marrow Niche, Enhances B-Cell Precursor-Acute Lymphoblastic Leukemic Cell Migratory and Invasive Properties (2018) (1)
Negative prognostic impact of electrolyte disorders in patients hospitalized for Covid-19 in a large multicenter study (2022) (0)
BCR::ABL1-Positive Acute Lymphoblastic Leukemia: Different Clinical Behavior and Relevance of Prognostic Features in Typical ALL and in CML-like Disease (2022) (0)
Ethmoid Adenocarcinoma (2010) (0)
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome (2023) (0)
EP1211: RADIOMICS-BASED MODEL FOR OUTCOME PREDICTION IN PRIMARY SCLEROSING CHOLANGITIS (2022) (0)
Identification Of Low Risk Group In Infants With Acute Lymphoblastic Leukemia By Flow Cytometric Minimal Residual Disease Measurement At Day 15 Of Interfant-99 and Interfant-06 Protocols Treatment (2013) (0)
Clinical Goals of Targeted Therapy in Childhood ALL (2011) (0)
1070 PROGNOSTIC PERFORMANCE OF CARDIAC MAGNETIC RESONANCE IMAGING MARKERS VERSUS COMPLICATED CLINICAL PRESENTATION AFTER AN ACUTE MYOCARDITIS (2022) (0)
INTRODUCTION TO BIOSTATISTICS. A GUIDE TO DESIGN, ANALYSIS, AND DISCOVERY. R. N. Forthofer and E. S. Lee, Academic Press, San Diego, 1995. No. of pages: 567. Price: $59.95. ISBN: 0‐12‐262270‐7 (1997) (0)
Non-parametric estimation of survival probabilities with a time-dependent exposure switch: application to (simulated) heart transplant data (2018) (0)
Methods for the validation of a highly skewed continuous surrogate endpoint for a time to event endpoint. (2018) (0)
A multicenter randomized trial comparing cyclophosphamide +platinum(CP)with platinum(P)alone in advanced ovarian cancer(AOC) (1993) (0)
Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality (2022) (0)
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 (2022) (0)
leukemia : results in 3184 patients of the AIEOP-BFM ALL 2000 study children and adolescents with B-cell precursor acute lymphoblastic Molecular response to treatment redefines all prognostic factors in (2010) (0)
P973 VALUE-BASED APPROACH TO HEPATOCELLULAR CARCINOMA: OUTCOME INDICATORS TESTED IN A LARGE MULTICENTER STUDY (VBMH STUDY) (2014) (0)
How should childhood acute lymphoblastic leukemia relapses in low‐income and middle‐income countries be managed: The AHOPCA‐ALL study group experience (2022) (0)
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy (2009) (0)
Cut-Point Finding Methods For Continuous Biomarkers In The Presence Of Binary And Censored Failure Time Outcome (2014) (0)
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia. (2023) (0)
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I (2017) (0)
childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study Late MRD response determines relapse risk overall and in subsets of (2013) (0)
ENCCA - EUROPEAN ACTIVITIES AND ACHIEVEMENTS WITH POTENTIAL INTEREST OUTSIDE OF EUROPE (2015) (0)
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management (2014) (0)
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single‐centre cohort (2022) (0)
Looking for the perfect test (if it exists) for the assessment of chromosome alterations in bladder cancer: Urovysion test and microarray-based CGH analysis (2011) (0)
Efficacy, pharmacokinetics, and safety in the mouse and primate retina of dual AAV vectors for Usher syndrome type 1B (2023) (0)
Characterization of cancer stem-like cells by detecting chromosomal aberrations in bladder cancer (2011) (0)
3159 – PH-LIKE AND IKZF1PLUS FEATURES IN CHILDREN WITH DOWN SYNDROME ACUTE LYMPHOBLASTIC LEUKAEMIA (2022) (0)
New approaches for the validation of a highly skewed surrogate for a survival endpoint (2019) (0)
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia (2019) (0)
Beware of biases in observational studies on anti-spike monoclonal antibodies. (2021) (0)
Analysis of recurrent complications with intermittent exposure and time-varying treatment in cancer (2008) (0)
Comparison of MRD Monitoring By IG/TR Rearrangement and BCR/ABL1 Transcript in Ph+ Pediatric Acute Lymphoblastic Leukemia Patients Treated with Imatinib in the Esphall Study (2014) (0)
Correction: Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point (2022) (0)
Provider Perceptions Of Clinical Neuropathy Examination Usefulness (2013) (0)
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (2020) (0)
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study (2015) (0)
Three-Drug Induction and BFM-Type Intensive Consolidation Chemotherapy for Treatment of Standard Risk Childhood Acute Lymphoblastic Leukemia Defined Also by DNA index. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Study ALL-9501. (2004) (0)
285 Tailored treatment of childhood ALL (2009) (0)
[OP.4A.04] NON-INVASIVE HEMODYNAMIC MONITORING AS A GUIDE TO DRUG TREATMENT OF UNCONTROLLED HYPERTENSIVE PATIENTS: HOME BLOOD PRESSURE IN THE BEAUTY STUDY (2017) (0)
Carotid plaque echolucency predicts the effectiveness of brain protection devices in carotid stenting: The ICAROS study (2004) (0)
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years, (2011) (0)
Atrial fibrillation incidence in SARS-CoV-2 infected patients: predictors and relationship with in-hospital mortality (2022) (0)
Response to "Low serum adiponectin levels and endothelial dysfunction in childhood hypertension". (2013) (0)
Kinesiotaping for rotator cuff disease (2017) (0)
Study )rearranged acute lymphoblastic leukemia: results from the Interfant-99 MLL ( mixed-lineage-leukemia poor prognostic subgroup of infants with Improved outcome with hematopoietic stem cell transplantation in a (2010) (0)
Sample size for recurrent events data in non randomized studies with an historical control (2008) (0)
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis. (2022) (0)
Role of MRD in Ph+ Pediatric Acute Lymphoblastic Leukemia Patients Treated with and without Tirosine Kinase Inhibitor in the Esphall Study (2012) (0)
Rhabdomyosarcoma in low- and middle-income countries: A report from the Asociacion de Hemato-oncología Pediatrica de Centro América (AHOPCA). (2022) (0)
Flow Cytometric Measurement of the Initial In Vivo Response to Prednisone Provides New Prognostic Information in Childhood Acute Lymphoblastic Leukemia (ALL) (2018) (0)
Permutation Tests to Compare Survival Curves for Matched Data Test di Permutazione per il Confronto di Curve di Sopravvivenza per Dati Appaiati (2005) (0)
Immunomodulatory Interventions Based on Minimal Residual Disease before and after Transplantation for Childhood Acute Lymphoblastic Leukemia (2016) (0)
Supplementary tables/figures and referecences to A Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy Induced Peripheral Neurotoxicity. (2021) (0)
P477 VALUE-BASED OUTCOME INDICATORS IN LIVER CIRRHOSIS: VALIDATION IN A LARGE MULTICENTER STUDY (VBMH STUDY) (2014) (0)
Prescribing patterns of antithrombotic drugs to elderly patients with atrial fibrillation admitted to an acute geriatric unit (2015) (0)
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response (2022) (0)
erythropoiesis in humans in vivo: data from the HIGHCARE project Modulation of hepcidin production during hypoxia-induced (2012) (0)
Posterior fossa syndrome in a population of children and young adults with medulloblastoma: a retrospective, multicenter Italian study on incidence and pathophysiology in a histologically homogeneous and consecutive series of 136 patients (2022) (0)
The care and outcomes of older persons with lung cancer in England and US, 2008–2012 (2018) (0)
Prognostic Value of Immunophenotype In Infant ALL – Results of the INTERFANT'99 Study (2010) (0)
Evaluation of Minimal Residual Disease As a Surrogate Endpoint for Event Free Survival in Childhood B-Lineage Acute Lymphoblastic Leukemia (2016) (0)
Refinement of IKZF1 Genomic Status in Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia (2014) (0)
Experience over 25 Years From Craniofacial to Endoscopic Resections : A Single-Institution − − Ethmoid Adenocarcinoma (2011) (0)
The Validation of a candidate surrogate of a Survival Endpoint in Leukemia (2015) (0)
Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale. (2020) (0)
Interfant-99 protocol Outcome of congenital acute lymphoblastic leukemia treated on the (2013) (0)
LYMPHOID NEOPLASIA IKZF 1 status as a prognostic feature in BCR-ABL 1 – positive childhood ALL (2014) (0)
International Society for Clinical Biostatistics (ISCB) (2005) (0)
Factors Influencing Access to Transplant, Waitlist Mortality, and Post-Transplant Survival in the Italian National Heart Transplant Database (2019) (0)
Development of new methods for the validation of non standard distributions for the surrogate endpoint for a time to event endpoint. (2018) (0)
THE EUROPEAN ROADMAP TO HORIZON 2020 FOR CHILDREN AND ADOLESCENTS WITH CANCER - A LONG TERM SUSTAINABLE STRATEGY (2015) (0)
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis (2019) (0)
CL4 Marginal Structural Models Used in Estimating Cost-Effectiveness of Time-Varying Drug Therapy Using Adimistrative Databases. The Case of Statin in Secondary Prevention (2012) (0)
Imatinib long term effects study: three years of follow-up and assessment (2009) (0)
Purified Peripheral Autologous Stem Cell Transplant Versus Conventional Chemotherapy for Childhood Low Risk Relapsed Acute Lymphoblastic Leukemia. (2006) (0)
A multidisciplinary approach to screen the post-COVID-19 conditions (2023) (0)
outcome, and provides therapeutic options MLL-rearranged infant acute lymphoblastic leukemia, influences clinical Specific promoter methylation identifies different subgroups of (2013) (0)
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia. (2023) (0)
Contribution Are Chronic Myeloid Leukemia Patients More at Risk for Second Malignancies ? A Population-based Study (2010) (0)
CI-FISH, GEP, and SNPs Correlate Genomic Categories with Risk Stratification in Children with T-ALL (2012) (0)
[OP.LB03.02] NON-INVASIVE HEMODYNAMIC MONITORING IN UNCONTROLLED HYPERTENSIVE PATIENTS: EFFECT ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE THE BEAUTY STUDY (2016) (0)
Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases (2020) (0)
30 Liver transplantation for cystic fibrosis-related liver disease (2003) (0)
1 Targeting FLT 3 in primary MLL gene rearranged infant acute lymphoblastic leukemia (2005) (0)
Author's response to reviews Title:Optimal cut-point definition in biomarkers: the case of censored failure time outcome Authors: (2014) (0)
Association Between Sex Hormones Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study (2021) (0)
[Situs ambiguus and atrial isomerism. Angiographic analysis of associated congenital heart diseases]. (1985) (0)
Hypersensitivity Reactions to Native E. coli L-Asparaginase in Children with Acute Lymphoblastic Leukemia May Vary By Treatment Schedule and Type of Glucocorticoid in Induction: Results of Trial ALL-BFM 2000 (2022) (0)
A model of clinical trial focused on caring procedure: The «Prone-Supine Study» protocol (2000) (0)
The chemerin/CMKLR1 axis regulates intestinal graft-versus-host disease (2023) (0)
Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP) (2018) (0)
Recursive partition methods for the analysis of prognostic factors in advanced ovarian cancer (1991) (0)
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study (2015) (0)
Long Term Results of the AIEOP-All-95 Trial for Childhood Acute Lymphoblastic Leukemia. An Insight on the Prognostic Value of Dna Index in the Frame of BFM-Based Chemotherapy. (2007) (0)
The validation of a highly skewed surrogate for a survival endpoint: new approaches (2019) (0)
Incidence and Therapeutic Implications of Germline TP53 Mutations in Hypodiploid Childhood Acute Lymphoblastic Leukemia: A Retrospective Analysis of the Italian Cohort (2020) (0)
Ph-like and IKZF1plus Features in Children with Down Syndrome and B Cell Precursor Acute Lymphoblastic Leukemia (2022) (0)
348 Uric acid is associated with acute heart failure and cardiogenic shock at presentation in acute coronary syndrome patients (2021) (0)
Second Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia (2012) (0)
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) (2014) (0)
Results of a Multicentre, Randomized, Controlled Open-Label Study on the Use of Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease (GvHD) and Graft Failure (GF) in Patients with Non-Malignant Disorders (2019) (0)
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis (2021) (0)
Application of Marginal Structural Models to estimate the cost-effectiveness of drug therapy with longitudinal observational data (2013) (0)
ALL positive childhood - BCR-ABL1 status as a prognostic feature in IKZF1 (2014) (0)
Please feel free to contact us for any problems you can encounter during the data entry process. With best regards, Carlo Gambacorti-Passerini MD, Lucia Tornaghi RN, ILTE Coordination Office (2007) (0)
Impact of Additional Intensive L-Asparaginase Therapy during Consolidation Phase for High-Risk Acute Lymphoblastic Leukemia: Results of a Randomized Controlled Trial in the AIEOP-BFM ALL 2009 Protocol (2022) (0)
Cut-point identification in biomarkers for a censored failure time outcome (2013) (0)
Development and validation of a predictive model to identify the active phase of labor (2022) (0)
Delirium Increases In-Hospital and Post-Discharge Mortality in COVID-19 Patients: The FRACOVID Multicenter Prospective Study (2022) (0)
Poor Prognosis in Children with ABL-Class Fusion Positive B-Cell Acute Lymphoblastic Leukemia Treated According to AIEOP-BFM Protocols (2019) (0)
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) (2014) (0)
Preclinical Assessment of Non-Virally Engineered CD33.CAR Cytokine-Induced Killer (CIK) Cells in Chemoresistant AML Patient-Derived Xenografts (2019) (0)
Survival Analysis for Epidemiologic and Medical Research by SELVIN, S. (2009) (0)
Minimal Residual Disease and Outcome Characteristics in Infant KMT2A-Germline Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol (2021) (0)
Role of fat distribution indicators in the identification of hypertension in children (2007) (0)
The best potential treatment for recurrent hepatocellular carcinoma after surgery: a machine learning predictive model for treatment allocation based on an Italian multicentric database (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Maria Grazia Valsecchi?

Maria Grazia Valsecchi is affiliated with the following schools:

University of Milan
ETH Zurich
Hannover Medical School
University of Milano-Bicocca
University of Bologna